Research to Prevent Blindness

RPB Researcher Identifies Eye Cancer Cell

October 18, 2007--An RPB-supported researcher and a team of investigators at St. Jude Children's Research Hospital have identified the cell that gives rise to the eye cancer retinoblastoma, disproving a long-standing principle of nerve growth and development. The finding suggests for the first time that it may one day be possible for scientists to induce fully developed neurons to multiply and coax the injured brain to repair itself. 

In 2006, the same researcher, Michael A. Dyer, Ph.D., an RPB Career Development Award recipient, reported a breakthrough in the treatment of retinoblastoma. The new chemotherapeutic approach greatly reduces the size of tumors, allowing patients to save the affected eye, without causing side effects associated with standard chemotherapy.

Related News: Ocular Oncology

RPB logo

Grant from Research to Prevent Blindness and Castle Biosciences Supports Medical Student Research in Ocular Cancer

Research to Prevent Blindness and Castle Biosciences are partnering to provide new opportunities for medical students to pursue ocular cancer research.

Read More


How Cells Die Determines Whether Immune System Mounts Response

An RPB vision researcher's finding could have important implications in the treatment of autoimmune diseases and cancer.  Read story.Thomas A. Ferguson, Ph.D., Washington University School of Medicine,...

Read More



Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.